牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

昭衍新药（603127）

6.3

综合诊断：6.3分打败了97%的股票！

卖出
减持
中性
增持
买入

短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
长期趋势：
已有57家主力机构披露2025-06-30报告期持股数据，持仓量总计4994.15万股，占流通A股7.92%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

7.8分

7.3分

6.0分

2.8分

5.2分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：7.8技术面打败了93%的股票技术面评分前10的股票

近期的平均成本为33.62元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。

技术面得分最高的股票

平均成本

近期的平均成本为33.62元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"33.62","date":1756802391,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。

[{"date":"2025.09.03","stock":"3.47","trade":"-0.22","ind":"-1.16"},{"date":"2025.09.02","stock":"-1.25","trade":"-2.00","ind":"-0.45"},{"date":"2025.09.01","stock":"4.21","trade":"2.46","ind":"0.46"},{"date":"2025.08.29","stock":"1.88","trade":"1.94","ind":"0.37"},{"date":"2025.08.28","stock":"-3.66","trade":"-0.23","ind":"1.14"},{"date":"2025.08.27","stock":"0.16","trade":"-2.37","ind":"-1.76"},{"date":"2025.08.26","stock":"-2.89","trade":"-2.26","ind":"-0.39"},{"date":"2025.08.25","stock":"5.38","trade":"2.72","ind":"1.51"},{"date":"2025.08.22","stock":"0.13","trade":"0.42","ind":"1.45"},{"date":"2025.08.21","stock":"0.06","trade":"0.08","ind":"0.13"},{"date":"2025.08.20","stock":"-3.26","trade":"-0.66","ind":"1.04"},{"date":"2025.08.19","stock":"-2.87","trade":"-0.88","ind":"-0.02"},{"date":"2025.08.18","stock":"0.55","trade":"1.40","ind":"0.85"},{"date":"2025.08.15","stock":"2.33","trade":"2.16","ind":"0.83"},{"date":"2025.08.14","stock":"-5.74","trade":"-0.94","ind":"-0.46"},{"date":"2025.08.13","stock":"9.16","trade":"2.16","ind":"0.48"},{"date":"2025.08.12","stock":"0.35","trade":"-0.47","ind":"0.50"},{"date":"2025.08.11","stock":"3.38","trade":"2.39","ind":"0.34"},{"date":"2025.08.08","stock":"0.27","trade":"-0.03","ind":"-0.12"},{"date":"2025.08.07","stock":"-3.18","trade":"-0.68","ind":"0.16"},{"date":"2025.08.06","stock":"-1.02","trade":"-1.04","ind":"0.45"}]

昭衍新药,上证指数,医疗服务指数

压力支撑

该股压力位为33.11元，支撑位为31.89元。

[{"text":"\u538b\u529b\u4f4d","value":"33.11","date":1756828800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"31.89","date":1756828800,"color":"0x0b52a1"}]

多空趋势

多头行情中，上涨趋势有所减缓，可适量做高抛低吸。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：7.3资金面打败了99%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码很集中，呈高度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

医疗服务行业，近5日资金总体无进出。

更新时间：09月03日 20:30

机构今日流向(万元)	-1431.49	机构5日流向(万元)	-451.12
机构10日流向(万元)	-10803.91	机构20日流向(万元)	-27827.55

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量减少1627.12万股，其中基金净减仓1家，主力净减仓58家，请投资者中长期谨慎为宜。

截止2025-06-30，共57家主力机构（基金55家，一般法人2家），持仓量总计4994.15万股，占流通A股7.92%
其中，基金持仓与2024-12-31相比：
增仓：4家，增持 232.03万股
减仓：5家，减持 105.14万股
新出现在主力名单中：45家，持有1978.69万股
从主力名单中消失：103家，原持有3829.72万股

消息面诊股

诊断结果：6消息面打败了91%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	分红转增	不分配不转增	2025-08-27
利好	业绩预告	预计扭亏	2025-07-15
一般消息	股东大会	外资股类别股东大会	2025-05-27
利好	分红转增	10派0.3元(含税)	2025-03-29
一般消息	重大事项	关联交易	2025-03-29
重大利空	业绩预告	业绩大幅下降	2025-01-25
一般消息	高管变动	连续担任公司独立董事期限即将满六年	2025-01-23
一般消息	重大事项	关联交易	2024-12-21
一般消息	高管变动	个人及工作原因	2024-12-20
一般消息	高管变动	因个人及工作原因	2024-10-30

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	1条	1条	0条

行业面诊股

诊断结果：2.8行业面打败了52%的股票医疗服务行业最新资金流向

近10日来该行业走势不明显，跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2025.09.03","price":"-1.16","value":"-0.22"},{"date":"2025.09.02","price":"-0.45","value":"-2.00"},{"date":"2025.09.01","price":"0.46","value":"2.46"},{"date":"2025.08.29","price":"0.37","value":"1.94"},{"date":"2025.08.28","price":"1.14","value":"-0.23"},{"date":"2025.08.27","price":"-1.76","value":"-2.37"},{"date":"2025.08.26","price":"-0.39","value":"-2.26"},{"date":"2025.08.25","price":"1.51","value":"2.72"},{"date":"2025.08.22","price":"1.45","value":"0.42"},{"date":"2025.08.21","price":"0.13","value":"0.08"},{"date":"2025.08.20","price":"1.04","value":"-0.66"},{"date":"2025.08.19","price":"-0.02","value":"-0.88"},{"date":"2025.08.18","price":"0.85","value":"1.40"},{"date":"2025.08.15","price":"0.83","value":"2.16"},{"date":"2025.08.14","price":"-0.46","value":"-0.94"},{"date":"2025.08.13","price":"0.48","value":"2.16"},{"date":"2025.08.12","price":"0.50","value":"-0.47"},{"date":"2025.08.11","price":"0.34","value":"2.39"},{"date":"2025.08.08","price":"-0.12","value":"-0.03"},{"date":"2025.08.07","price":"0.16","value":"-0.68"},{"date":"2025.08.06","price":"0.45","value":"-1.04"}]

上证指数,医疗服务行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	创新医疗	49.43%	4.45%	5.7分
2	皓元医药	29.82%	16.78%	6.9分
3	皓宸医疗	29.61%	4.23%	5.5分
4	百花医药	29.60%	17.21%	6.5分
5	南模生物	26.84%	-9.84%	5.1分
6	阳光诺和	21.77%	8.63%	6.1分
7	成都先导	21.11%	29.15%	6.8分
8	药明康德	18.49%	16.23%	6.8分
9	毕得医药	17.67%	10.58%	5.6分
10	博腾股份	16.64%	14.88%	6.3分
11	盈康生命	15.32%	11.56%	6.3分
12	普蕊斯	14.65%	24.61%	5.7分
13	三博脑科	14.60%	0.85%	4.7分
14	华康洁净	10.56%	4.44%	5.7分
15	ST中珠	9.76%	-5.26%	4.3分
16	美迪西	9.60%	7.29%	6.2分
17	康龙化成	8.22%	8.15%	6.2分
18	昭衍新药	7.53%	4.50%	6.3分
19	百诚医药	5.15%	14.71%	5.8分
20	迪安诊断	4.98%	-3.60%	5.3分
21	药康生物	3.15%	0.87%	5.9分
22	九洲药业	2.28%	5.77%	6.4分
23	诚达药业	1.26%	-4.04%	4.8分
24	通策医疗	0.75%	-2.72%	5.0分
25	泰格医药	0.30%	3.63%	5.5分
26	凯莱英	-0.43%	6.45%	6.0分
27	新里程	-0.46%	-4.02%	4.7分
28	睿智医药	-0.71%	1.86%	5.1分
29	美年健康	-0.75%	-9.62%	4.7分
30	爱尔眼科	-1.25%	-4.31%	5.4分
31	金域医学	-1.47%	-7.02%	4.7分
32	华厦眼科	-1.57%	-2.42%	5.0分
33	金凯生科	-1.90%	-4.41%	4.5分
34	泓博医药	-2.05%	0.58%	5.3分
35	诺思格	-2.15%	6.60%	5.7分
36	博济医药	-2.48%	-2.84%	4.3分
37	澳洋健康	-3.06%	-2.60%	5.4分
38	华大基因	-3.72%	-6.63%	4.4分
39	和元生物	-3.76%	-3.88%	4.9分
40	益诺思	-5.41%	3.01%	5.0分
41	国际医学	-5.55%	-4.31%	5.2分
42	药石科技	-5.56%	1.13%	4.6分
43	奥浦迈	-6.09%	1.35%	5.2分
44	贝瑞基因	-6.13%	-10.07%	4.7分
45	诺禾致源	-7.94%	-4.16%	5.0分
46	何氏眼科	-8.09%	-4.49%	4.5分
47	普瑞眼科	-8.41%	-11.55%	4.8分
48	光正眼科	-8.99%	-2.75%	5.0分
49	万邦医药	-9.01%	-2.00%	4.4分
50	兰卫医学	-10.46%	-5.29%	4.8分
51	海特生物	-17.83%	-13.20%	4.3分
52	*ST生物	-19.21%	1.99%	4.5分
53	-	-	153.01%	分

<上一页 1 2 3 4 5...9 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：5.2基本面打败了29%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（82.5分）

基本面得分最高的股票

[ 截止日期：2025-06-30 ]公司经营

盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 32/101 ， 44/101。

[{"date":"2025-06-30","value":"0.75","vol":"2.23"},{"date":"2025-03-31","value":"0.51","vol":"0.92"},{"date":"2024-12-31","value":"0.91","vol":"-0.15"},{"date":"2024-09-30","value":"-0.86","vol":"3.24"},{"date":"2024-06-30","value":"-2.10","vol":"2.52"}]

	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
净资产收益率(%)	0.75	0.51	0.91	-0.86	-2.10
行业(%)	2.23	0.92	-0.15	3.24	2.52

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-06-30","value":"24.03","vol":"36.06"},{"date":"2025-03-31","value":"28.61","vol":"34.67"},{"date":"2024-12-31","value":"28.43","vol":"34.77"},{"date":"2024-09-30","value":"27.48","vol":"36.16"},{"date":"2024-06-30","value":"30.37","vol":"36.37"}]

	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
销售毛利率(%)	24.03	28.61	28.43	27.48	30.37
行业(%)	36.06	34.67	34.77	36.16	36.37

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 48/101 ， 5/101。

[{"date":"2025-06-30","value":"-21.28","vol":"2.42"},{"date":"2025-03-31","value":"-11.54","vol":"-0.08"},{"date":"2024-12-31","value":"-15.07","vol":"-0.73"},{"date":"2024-09-30","value":"-15.87","vol":"0.87"},{"date":"2024-06-30","value":"-16.08","vol":"0.65"}]

	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
营业收入同比增长率(%)	-21.28	-11.54	-15.07	-15.87	-16.08
行业(%)	2.42	-0.08	-0.73	0.87	0.65

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-06-30","value":"135.90","vol":"-71.46"},{"date":"2025-03-31","value":"115.11","vol":"-25.93"},{"date":"2024-12-31","value":"-81.34","vol":"-96.53"},{"date":"2024-09-30","value":"-121.46","vol":"-161.08"},{"date":"2024-06-30","value":"-287.30","vol":"-107.95"}]

	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
净利润同比增长率(%)	135.90	115.11	-81.34	-121.46	-287.30
行业(%)	-71.46	-25.93	-96.53	-161.08	-107.95

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 51/101 ， 51/101。

[{"date":"2025-06-30","value":"0.07","vol":"0.20"},{"date":"2025-03-31","value":"0.03","vol":"0.10"},{"date":"2024-12-31","value":"0.21","vol":"0.41"},{"date":"2024-09-30","value":"0.14","vol":"0.31"},{"date":"2024-06-30","value":"0.09","vol":"0.20"}]

	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
总资产周转率(次)	0.07	0.03	0.21	0.14	0.09
行业(次)	0.20	0.10	0.41	0.31	0.20

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-06-30","value":"0.33","vol":"7.41"},{"date":"2025-03-31","value":"0.14","vol":"3.76"},{"date":"2024-12-31","value":"0.86","vol":"16.35"},{"date":"2024-09-30","value":"0.55","vol":"14.25"},{"date":"2024-06-30","value":"0.34","vol":"8.86"}]

	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
存货增长率(次)	0.33	0.14	0.86	0.55	0.34
行业(次)	7.41	3.76	16.35	14.25	8.86

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 15/101 ， 38/101。

[{"date":"2025-06-30","value":"25.61","vol":"15.87"},{"date":"2025-03-31","value":"22.67","vol":"-1.69"},{"date":"2024-12-31","value":"21.46","vol":"22.34"},{"date":"2024-09-30","value":"7.12","vol":"12.23"},{"date":"2024-06-30","value":"7.20","vol":"9.92"}]

	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
现金流量净额/营业收入	25.61	22.67	21.46	7.12	7.20
行业	15.87	-1.69	22.34	12.23	9.92

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-06-30","value":"1.14","vol":"0.94"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.82","vol":"1.31"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.79","vol":"1.44"}]

	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
资本支出／折旧和摊销	1.14	-	1.82	-	1.79
行业	0.94	0.00	1.31	0.00	1.44

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 41/101 ， 29/101。

[{"date":"2025-06-30","value":"4.52","vol":"3.69"},{"date":"2025-03-31","value":"4.61","vol":"3.84"},{"date":"2024-12-31","value":"4.53","vol":"3.70"},{"date":"2024-09-30","value":"4.11","vol":"4.11"},{"date":"2024-06-30","value":"3.62","vol":"4.14"}]

	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
流动比率	4.52	4.61	4.53	4.11	3.62
行业	3.69	3.84	3.70	4.11	4.14

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-06-30","value":"2.10","vol":"2.98"},{"date":"2025-03-31","value":"2.26","vol":"3.12"},{"date":"2024-12-31","value":"2.44","vol":"3.01"},{"date":"2024-09-30","value":"2.74","vol":"3.38"},{"date":"2024-06-30","value":"2.45","vol":"3.39"}]

	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
速动比率	2.10	2.26	2.44	2.74	2.45
行业	2.98	3.12	3.01	3.38	3.39

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 44/101 ， 44/101。

[{"date":"2025-06-30","value":"14.44","vol":"32.65"},{"date":"2025-03-31","value":"13.96","vol":"32.24"},{"date":"2024-12-31","value":"14.02","vol":"32.31"},{"date":"2024-09-30","value":"16.11","vol":"31.03"},{"date":"2024-06-30","value":"18.07","vol":"31.65"}]

	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
资产负债率(%)	14.44	13.96	14.02	16.11	18.07
行业(%)	32.65	32.24	32.31	31.03	31.65

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-06-30","value":"0.17","vol":"0.95"},{"date":"2025-03-31","value":"0.16","vol":"0.98"},{"date":"2024-12-31","value":"0.16","vol":"1.01"},{"date":"2024-09-30","value":"0.19","vol":"0.85"},{"date":"2024-06-30","value":"0.22","vol":"0.87"}]

	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
产权比率 (%)	0.17	0.16	0.16	0.19	0.22
行业(%)	0.95	0.98	1.01	0.85	0.87

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"5.57","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"10.74","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.97","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.74","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"2.99","blueLineValue":"0.40","type":"YC"}]

[昭衍新药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]